×
For best experience we recommend to activate Javascript in your browser.
DCK antibody (C-Term)
DCK
Reactivity: Human, Mouse
WB, IF, IP, IHC (p)
Host: Rabbit
Polyclonal
RB05276
unconjugated
Product Details anti-DCK Antibody
(hide)
Target
See all DCK Antibodies
DCK
(Deoxycytidine Kinase (DCK))
Binding Specificity
All epitopes for DCK antibodies
AA 171-200, C-Term
Reactivity
All reactivities for DCK antibodies
Human, Mouse
Host
All hosts for DCK antibodies
Rabbit
Clonality
All clonalities for DCK antibodies
Polyclonal
Conjugate
All conjugates for DCK antibodies
This DCK antibody is un-conjugated
Application
All applications for DCK antibodies
Western Blotting (WB), Immunofluorescence (IF), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Purification
This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Immunogen
This DCK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 171-200 amino acids from the C-terminal region of human DCK.
Clone
RB05276
Isotype
Ig Fraction
Top Product
Discover our top product DCK Primary Antibody
Alternatives
(show)
Application Details
(hide)
Application Notes
IF: 1:10~50. IP: 1:500~1000. WB: 1:1000. IHC-P: 1:10~50
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date
6 months
References for anti-DCK antibody (ABIN391125)
(hide)
Hartford, Duan, Delaney, Mi, Kistner, Lamba, Huang, Dolan : "Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity. " in: Blood , Vol. 113 , Issue 10 , pp. 2145-53 , (2009 ) (PubMed ).
Lamba, Crews, Pounds, Schuetz, Gresham, Gandhi, Plunkett, Rubnitz, Ribeiro : "Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants. " in: The Journal of pharmacology and experimental therapeutics , Vol. 323 , Issue 3 , pp. 935-45 , (2007 ) (PubMed ).
Target Details for DCK
(hide)
Target
DCK
(Deoxycytidine Kinase (DCK))
Alternative Name
DCK (DCK Products )
Synonyms
dck antibody, DCK antibody, wu:fc15f06 antibody, zgc:101771 antibody, dck1 antibody, deoxycytidine kinase antibody, deoxycytidine kinase, gene 2 L homeolog antibody, deoxycytidine kinase, gene 2 antibody, Deoxycytidine kinase antibody, deoxycytidine kinase, gene 1 L homeolog antibody, DCK antibody, dck antibody, dck.2.L antibody, dck.2 antibody, Dck antibody, FPV059 antibody, FPV151 antibody, dck.1.L antibody
Background
Deoxycytidine kinase is responsible for the phosphorylation of several deoxyribonucleosides and their analogs. Deficiency of this enzyme activity is associated with resistance to antiviral and anticancer chemotherapeutic agents, whereas increased enzyme activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. It is the rate limiting enzyme in the activation of many important anticancer and retroviral drugs and its activity is often decreased in cells that are resistant to cytosine arabinoside.
Molecular Weight
30519
Gene ID
1633
NCBI Accession
NP_000779
UniProt
P27707
Recently viewed
(hide)